Abiraterone Acetate Tablets

Name: Abiraterone Acetate Tablets
Brand: Welox Pharma Private Limited

Get a Price/Quote

MOQ : 100 Boxes

Abiraterone Acetate Tablets Specification

Salt Composition
Abiraterone Acetate

Dosage Form
Tablet

Indication
Used for the treatment of metastatic castration-resistant prostate cancer (mCRPC)

Enzyme Types
CYP17 inhibitor

Feature
Potent oral antiandrogen therapy for prostate cancer

Ingredients
Abiraterone Acetate and excipients

Application
Oral administration

Physical Color/Texture
White to off-white, oval-shaped film-coated tablet

Enzymatic Activity
Inhibits androgen biosynthesis by blocking CYP17A1 enzyme

Storage Instructions
Store below 30C, keep in a dry place protected from light

Shelf Life
24 months from manufacturing date

Strength
250 mg or 500 mg per tablet (available strengths)

Marketed By
Stated on packaging

Regulatory Status
Rx - Prescription only

Packaging Type
HDPE bottle or blister pack

ATC Code
L02BX03

Warning
Not for use in women or children; caution required for hepatic impairment

Route of Administration
Oral

Prescription Required
Yes

Patient Population
Adult male

Abiraterone Acetate Tablets Trade Information

Minimum Order Quantity
100 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Boxes Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Abiraterone Acetate Tablets

Discover best price and lowest price offers on Abiraterone Acetate Tablets, available for a limited time only. These first-rate, sought-after tablets come in pristine 250 mg or 500 mg strengths, elegantly packaged in immaculate HDPE bottles or convenient blister packs. Specifically designed for adult males with metastatic castration-resistant prostate cancer (mCRPC), this potent oral antiandrogen therapy blocks CYP17A1 enzyme activity to help manage cancer progression. Prescription required. For your safety, not for use in women, children, or those with hepatic impairment. Marketed by trusted suppliers from India, each tablet is white to off-white, oval-shaped, and film-coated, promising both efficacy and impeccable quality.

Advanced Site of Application and Therapeutic Usage

Abiraterone Acetate Tablets are taken orally, designed to treat advanced metastatic castration-resistant prostate cancer (mCRPC) in adult males. The product exhibits potent antiandrogen activity by inhibiting the CYP17A1 enzyme, directly blocking androgen biosynthesis. These immaculate tablets exemplify first-rate, targeted cancer therapy, providing a sought-after and effective option for eligible patients. Consult your healthcare provider to ensure optimal dosing and safe administration to maximize benefits and manage potential risks.

Comprehensive Packaging & Certifications for Safe Handover

Available in either durable HDPE bottles or secure blister packs, Abiraterone Acetate Tablets benefit from rigorous goods transport and logistics standards to maintain product integrity during handover. Each package includes clear labeling of manufacturers and suppliers, along with strict handling and storage instructions. Certified for prescription-only distribution, the product comes with a 24-month shelf life, consistently adhering to sample policy and regulatory compliance. Our logistics partners ensure timely and safe delivery to authorized channels nationwide.

FAQ's of Abiraterone Acetate Tablets:

Q: How should Abiraterone Acetate Tablets be taken?

A: Abiraterone Acetate Tablets are intended for oral use only and must be taken as prescribed by your healthcare provider. Swallow the tablets whole with water, preferably on an empty stomach, and follow your physician's instructions or the guidance provided on the packaging.

Q: What conditions are Abiraterone Acetate Tablets used for?

A: These tablets are primarily used for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adult male patients. It works by inhibiting the CYP17 enzyme, effectively reducing androgen production involved in cancer growth.

Q: When should I avoid using Abiraterone Acetate Tablets?

A: Abiraterone Acetate Tablets should not be used by women, children, or individuals with significant hepatic impairment. Always consult your healthcare provider before beginning the treatment to rule out contraindications and ensure safety.

Q: Where can I find information about the manufacturer or supplier?

A: The manufacturer and supplier details are clearly stated on the product packaging. For additional verification, you may contact your pharmacy or healthcare provider.

Q: What measures are taken during the transport and logistics of Abiraterone Acetate Tablets?

A: The tablets are handled using secure goods transport and logistical standards to ensure product safety. The packaging, whether HDPE bottle or blister pack, is designed to maintain pharmaceutical integrity until handover to authorized facilities.

Q: How do I benefit from using Abiraterone Acetate Tablets?

A: When used under medical supervision, these tablets offer potent antiandrogen therapy that helps slow prostate cancer progression, aiming to improve clinical outcomes and quality of life for eligible patients.